Regulation of human eotaxin generation by Th1-/Th2-derived cytokines

被引:23
作者
Miyamasu, M
Misaki, Y
Yamaguchi, M
Yamamoto, K
Morita, Y
Matsushima, K
Nakajima, T
Hirai, K
机构
[1] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138655, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan
[4] Univ Tokyo, Grad Sch Med, CRESAT, Bunkyo Ku, Tokyo 1138655, Japan
关键词
eotaxin; fibroblast; allergy; eosinophil; TNF-alpha; IL-4; IFN-gamma; Th1/Th2; paradigm;
D O I
10.1159/000053634
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Accumulating evidence indicates that eotaxin is the primary mediator of tissue eosinophilia. In the present study, we analyzed the mechanisms of eotaxin generation by Th1-/Th2-derived cytokines in vitro. Methods: Human dermal fibroblasts, human umbilical vein endothelial cells and A549 human bronchial epithelial cell line cells were stimulated with TNF-alpha, IL-4, IFN-gamma or TNF-alpha in combination with IL-4 or IFN-gamma and the amount of eotaxin production was analyzed. Results: Fibroblasts produced nanogram/milliliter quantities of eotaxin. Proinflammatory cytokine TNF-alpha and Th2-type cytokine IL-4 each induced eotaxin production, and combination of them caused a marked synergistic increase in that production. On the other hand, Th1-type cytokine IFN-gamma inhibited eotaxin generation at the protein/mRNA levels. Conclusion: The Th2-derived cytokine upregulated while the Th1-derived cytokine inhibited eotaxin production by fibroblasts. In view of the Th1/Th2 paradigm, these results indicate that (1) eotaxin regulates eosinophil accumulation in the Th2-dominant state such as allergic disease, and (2) direct suppression of eotaxin production by IFN-gamma is one of the major mechanisms by which IFN-gamma suppresses eosinophilic inflammation. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:54 / 58
页数:5
相关论文
共 19 条
[1]   Human dermal fibroblasts express eotaxin: Molecular cloning, mRNA expression, and identification of eotaxin sequence variants [J].
Bartels, J ;
Schluter, C ;
Richter, E ;
Noso, N ;
Kulke, R ;
Christophers, E ;
Schroder, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :1045-1051
[2]   COOPERATION BETWEEN INTERLEUKIN-5 AND THE CHEMOKINE EOTAXIN TO INDUCE EOSINOPHIL ACCUMULATION IN-VIVO [J].
COLLINS, PD ;
MARLEAU, S ;
GRIFFITHSJOHNSON, DA ;
JOSE, PJ ;
WILLIAMS, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1169-1174
[3]   Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia [J].
GarciaZepeda, EA ;
Rothenberg, ME ;
Ownbey, RT ;
Celestin, J ;
Leder, P ;
Luster, AD .
NATURE MEDICINE, 1996, 2 (04) :449-456
[4]   Chemokine receptor usage by human eosinophils - The importance of CCR3 demonstrated using an antagonistic monoclonal antibody [J].
Heath, H ;
Qin, SX ;
Rao, P ;
Wu, LJ ;
LaRosa, G ;
Kassam, N ;
Ponath, PD ;
Mackay, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :178-184
[5]   INTERFERON-GAMMA REGULATES ANTIGEN-INDUCED EOSINOPHIL RECRUITMENT INTO THE MOUSE AIRWAYS BY INHIBITING THE INFILTRATION OF CD4+ T-CELLS [J].
IWAMOTO, I ;
NAKAJIMA, H ;
ENDO, H ;
YOSHIDA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :573-576
[6]   Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils [J].
Izumi, S ;
Hirai, K ;
Miyamasu, M ;
Takahashi, Y ;
Misaki, Y ;
Takaishi, T ;
Morita, Y ;
Matsushima, K ;
Ida, N ;
Nakamura, H ;
Kasahara, T ;
Ito, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :816-824
[7]   MECHANISMS OF ALLERGIC PULMONARY EOSINOPHILIA IN THE MOUSE [J].
KUNG, TT ;
STELTS, D ;
ZURCHER, JA ;
WATNICK, AS ;
JONES, H ;
MAUSER, PJ ;
FERNANDEZ, X ;
UMLAND, S ;
KREUTNER, W ;
CHAPMAN, RW ;
EGAN, RW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (06) :1217-1224
[8]  
Lamkhioued B, 1997, J IMMUNOL, V159, P4593
[9]   Expression of eotaxin by human lung epithelial cells - Induction by cytokines and inhibition by glucocorticoids [J].
Lilly, CM ;
Nakamura, H ;
Kesselman, H ;
NaglerAnderson, C ;
Asano, K ;
GarciaZepeda, EA ;
Rothenberg, ME ;
Drazen, JM ;
Luster, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1767-1773
[10]   Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation [J].
Miyamasu, M ;
Nakajima, T ;
Misaki, Y ;
Izumi, S ;
Tsuno, N ;
Kasahara, T ;
Yamamoto, K ;
Morita, Y ;
Hirai, K .
CYTOKINE, 1999, 11 (10) :751-758